Table 3.
Frequencies of participants showing no, mild, and moderate to severe symptoms of depression and anxiety as measured with PHQ-9 and GAD-7 pre-intervention, post-intervention, and follow-up.
| PHQ-9 (n/%) | GAD-7 (n/%) | |||||
|---|---|---|---|---|---|---|
| Cut-off | Pre | Post | FU | Pre | Post | FU |
| ATT | ||||||
| 0–4 (No symptoms) | 16/40.0 | 22/55.0 | 20/50.0 | 15/37.5 | 24/60.0 | 21/52.5 |
| 5–9 (Mild) | 12/30.0 | 12/30.0 | 15/37.5 | 18/45.0 | 13/32.5 | 17/42.5 |
| >10 (Moderate to severe) | 12/30.0 | 6/15.0 | 5/12.5 | 7/17.5 | 3/7.5 | 2/5.0 |
| MSC | ||||||
| 0–4 (No symptoms) | 14/34.1 | 22/53.7 | 21/51.2 | 14/34.1 | 21/51.2 | 20/48.8 |
| 5–9 (Mild) | 16/39.1 | 13/31.7 | 14/34.2 | 17/41.5 | 14/34.2 | 16/39.0 |
| >10 (Moderate to severe) | 11/26.8 | 6/14.6 | 6/14.6 | 10/24.4 | 6/14.6 | 5/12.2 |
ATT, Attention Training Technique; MSC, Mindful Self-Compassion; PHQ-9, Patient Health Questionnaire 9; GAD-7, Generalized Anxiety Disorder-7; FU, 6-month follow-up.